FDA Resolves Saline Shortage, Trump Health Commission Delays
The U.S. FDA has resolved the IV saline shortage while a Trump health commission report on children's health is delayed. New DNA study findings aid in evaluating heart risks in diabetes patients, and a report reveals acute malnutrition affecting thousands of children in Gaza.

The U.S. Food and Drug Administration announced it has successfully resolved the shortage of intravenous and injectable saline solutions, a critical supply issue that had led to postponing elective medical procedures nationwide last year.
The release of a Trump administration-era health commission report, aimed at tackling the 'chronic disease epidemic' affecting children and adults, is delayed past its initial deadline, raising anticipation and scrutiny.
Meanwhile, troubling health statistics emerge from Gaza as nearly 12,000 children under five are recorded with acute malnutrition and the harsh realities of a water crisis escalate further.
(With inputs from agencies.)
- READ MORE ON:
- FDA
- Trump
- health
- IV saline
- diabetes
- mRNA
- malnutrition
- Gaza
- insulin
- drug manufacturing
ALSO READ
Gaza's Humanitarian Crisis: Children Facing Dire Malnutrition
At least 652 children died from malnutrition in Nigeria in last six months, MSF says
Tragedy in Gaza: The Stark Reality of Infant Malnutrition
Malnutrition Crisis in Gaza Escalates: Children Dying as Aid Blockades Persist
Mounjaro Triumphs Over Trulicity: A New Era in Diabetes Care